BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 14750902)

  • 1. Repression of Smad4 transcriptional activity by SUMO modification.
    Long J; Wang G; He D; Liu F
    Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
    Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH
    J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.
    Chang CC; Lin DY; Fang HI; Chen RH; Shih HM
    J Biol Chem; 2005 Mar; 280(11):10164-73. PubMed ID: 15637079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.
    Ohshima T; Shimotohno K
    J Biol Chem; 2003 Dec; 278(51):50833-42. PubMed ID: 14514699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4.
    Lin X; Liang M; Liang YY; Brunicardi FC; Feng XH
    J Biol Chem; 2003 Aug; 278(33):31043-8. PubMed ID: 12813045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
    Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
    Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
    Nakagawa K; Kuzumaki N
    Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
    Zhang Y; Feng XH; Derynck R
    Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMOylation modulates transcriptional repression by TRPS1.
    Kaiser FJ; Lüdecke HJ; Weger S
    Biol Chem; 2007 Apr; 388(4):381-90. PubMed ID: 17391059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
    Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
    J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
    Kim EJ; Park JS; Um SJ
    Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
    Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells.
    Yukita A; Hosoya A; Ito Y; Katagiri T; Asashima M; Nakamura H
    Bone; 2012 May; 50(5):1092-9. PubMed ID: 22366399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO functions in constitutive transcription and during activation of inducible genes in yeast.
    Rosonina E; Duncan SM; Manley JL
    Genes Dev; 2010 Jun; 24(12):1242-52. PubMed ID: 20504900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of SOX6 transcriptional activity by SUMO modification.
    Fernández-Lloris R; Osses N; Jaffray E; Shen LN; Vaughan OA; Girwood D; Bartrons R; Rosa JL; Hay RT; Ventura F
    FEBS Lett; 2006 Feb; 580(5):1215-21. PubMed ID: 16442531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.